查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2034913

全球內視鏡取血管手術市場：市場規模、佔有率和趨勢分析（2026-2032 年）

Endoscopic Vessel Harvesting Market Size, Share & Trends Analysis | Global | 2026-2032
出版日期: | 出版商: iData Research Inc. | 英文 62 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球內視鏡取血管手術設備市場報告（至2032年）

2025年全球內視鏡取血管手術設備市場規模為3.509億美元。預計未來將以-0.7%的複合年成長率萎縮，到2032年達到3.35億美元。

本報告涵蓋了內視鏡取血管手術(EVH) 設備的全球市場，包括用於微創內視鏡手術（作為冠狀動脈繞道手術手術的一部分）的設備。

分析包括銷售量、平均售價 (ASP)、治療次數、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。

市場需求主要受內視鏡血管內取骨術（EVH）的臨床效益以及內視鏡取骨技術日益普及的驅動。然而，由於冠狀動脈繞道手術（CABG）數量的減少和價格競爭，預計整體市場規模將略有下降。

市場概覽

全球內視鏡取血管手術裝置市場包括用於透過微創內視鏡方法採集冠狀動脈繞道手術手術 (CABG) 所需血管的產品。

使用EVH裝置，外科醫生可以透過比傳統開放性手術更小的切口來獲取大隱靜脈和其他目標血管。這減輕了取血管部位的負擔，並有助於患者更快康復。

近年來，由於微創導管介入治療的不斷普及，全球冠狀動脈繞道手術手術的數量一直在下降。經導管主動脈瓣置換術（TAVR）和其他導管介入治療方法可縮短恢復時間並減少手術創傷，導致治療模式從一些開胸心血管手術轉向其他治療方式。

儘管面臨這些壓力，冠狀動脈繞道手術（CABG）對於複雜的多支血管冠狀動脈疾病仍然是臨床上必要的。這為需要血管獲取技術的手術維持了穩定的基礎，有助於抑制血管內取血管（EVH）器械市場在2032年之前的萎縮。

市場促進因素

臨床獲益

EVH裝置能夠透過較小的切口獲取所需的血管，從而實現微創血管獲取。與開胸血管獲取術相比，這減輕了獲取部位的負擔。

臨床效益包括減少瘢痕形成、加速術後恢復、提高患者滿意度。這些益處至關重要，因為血管取血管部位可能是冠狀動脈繞道手術（CABG）後引起不適和併發症的主要原因。

開胸手術需要更大的切口，且傷口併發症（如破裂、血腫和感染）的風險更高。內視鏡取卵裝置可透過降低這些風險，有助於改善患者預後，並維持對內視鏡取卵的需求。

滲透率的擴大

EVH 的應用率已經非常高。到 2025 年，EVH 方法將在超過 90% 的血管採集手術中使用。

預計在整個預測期內，此採用率將持續上升，接近100%。醫生們仍然更傾向於選擇EVH，因為它能為病人帶來短期和長期的益處。

即使冠狀動脈繞道手術（CABG）的數量下降，不斷提高的血管內膜剝脫術（EVH）普及率仍將有助於支撐市場。雖然手術總數可能會減少，但在剩餘的CABG手術中增加EVH的使用將緩解EVH設備市場的萎縮。

微創冠狀動脈繞道手術的管理

隨著微創和機器人輔助冠狀動脈繞道術的日益普及，對先進的血管內壁成形術（EVH）器械的需求也日益成長。這些手術更著重在空間受限的環境下進行操作以及高效血管預備所需的器械。

微創直接冠狀動脈繞道手術（CABG）和機器人輔助手術需要精準可靠的器械性能。血管內視鏡血管成形術（EVH）系統憑藉其更佳的視野、解剖、電凝和分支結紮能力，能夠支援這些更先進的手術流程。

製造商正透過改進設備設計、提升易用性和提高手術效率來應對這項挑戰。這些產品改進有助於推動血管內皮切除術（EVH）領域的持續創新，即便冠狀動脈繞道手術（CABG）的整體成長仍然有限。

市場限制

冠狀動脈繞道手術數量減少

冠狀動脈繞道手術（CABG）數量的下降是血管內血管重建（EVH）器械市場的主要限制因素。由於EVH器械僅用於CABG手術，因此該市場與血管重組手術的數量密切相關。

隨著微創導管介入手術的日益普及，冠狀動脈繞道手術（CABG）的數量預計將會下降。這將直接限制對血管採集裝置的需求。

儘管預計EVH裝置的下降速度將慢於開胸取心法，但整體市場仍將受到冠狀動脈旁路移植術（CABG）數量的限制。除非人口老化的影響足以扭轉CABG手術的當前趨勢，否則對EVH裝置的需求將持續有限。

競爭對手

競爭也是EVH設備市場的主要阻礙因素之一。在已開發市場，各公司之間展開了激烈的價格競爭。

隨著美國和歐洲新參與企業的出現，以及現有公司之間的持續競爭，預計平均售價（ASP）將穩定下降。

平均售價面臨的這種壓力將在整個預測期內抑制市場價值。即使電動車充電樁（EVH）的普及率提高，價格下跌也可能抵消部分因使用量增加而帶來的效益。

由於治療方法的組成而產生的壓力

EVH市場也受到心血管治療模式更廣泛變化的限制。隨著導管介入治療方法的不斷普及，一些以前需要接受冠狀動脈繞道手術手術（CABG）的患者現在或許能夠接受創傷較小的治療治療方法。

由於EVH是一種與外科搭橋手術相關的器械，而非基於導管的治療方法，因此這一趨勢將影響EVH市場。無論EVH的普及率如何成長，都無法完全抵消冠狀動脈繞道手術（CABG）數量的下降。

隨著治療途徑不斷轉向微創替代療法（在適當情況下），EVH 供應商需要關注剩餘的需要外科治療的患者群體，包括複雜病例和多支血管疾病病例，在這些病例中，CABG 在臨床上仍然需要。

市場覆蓋範圍和數據範圍

  • 量化範圍：市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售單位數量、平均售價。
  • 定性範圍：市場促進因素和阻礙因素、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
  • 目標時期：基準年為 2025 年，預測至 2032 年，歷史資料截至 2022 年。
  • 建立市場模型：根據手術數量、競爭市場佔有率分析和預測假設，使用銷售量和平均售價 (ASP) 分析收入。
  • 目標設備：本報告重點介紹用於微創血管採集手術（作為冠狀動脈繞道手術手術的一部分）的內視鏡取血管手術設備。

目標市場及區隔

內視鏡取血管手術裝置市場

本報告涵蓋了心臟外科器械領域內視鏡取血管手術裝置的全球市場。

在冠狀動脈繞道手術手術（CABG）中，會使用內視鏡血管攝影設備，透過微創內視鏡手術取得血管。這些設備可以縮小血管攝影所需的切口，有助於改善血管擷取部位的治療效果。

此市場分析依據市場規模、市場佔有率、手術數量、市場預測、市場成長率、銷售量和平均售價。

本報告根據 CABG 手術數量、醫生採用率、EVH 滲透率、競爭性定價、產品創新以及向微創手術技術的轉變來評估對 EVH 的需求。

這種配置使製造商、投資者和策略團隊能夠了解 CABG 趨勢、血管採集偏好、設備定價和競爭動態如何塑造全球 EVH 市場。

競爭分析

到 2025 年，Getinge 將憑藉其 VASOVIEW™ 平台在該領域佔據主導地位，並成為全球 EVH 設備市場的領先競爭者。

該公司於 2024 年推出新一代“VASOVIEW™ Hemopro 3”，進一步鞏固了其市場地位。該產品在設計和性能方面進行了改進，旨在提高微創冠狀動脈旁路移植術的效率。

憑藉強大的成功實施記錄和持續的產品創新，Getinge預計將在未來幾年內保持其市場佔有率。

2025年，泰爾茂是全球EVH設備市場第二大競爭對手。該公司提供VirtuoSaph™和VirtuoSaph™ Plus EVH系統。

預計未來幾年，泰爾茂將在全球多個地區擴大市場佔有率。該公司在心血管和外科器械市場的持續存在，凸顯了其在血管內皮生長因子（EVH）領域的競爭力。

2025年，Zimmer Biomet在全球內視鏡血管攝影（EVH）設備市場佔據第三大佔有率。該公司憑藉其Venapax®內視鏡取血管手術系統進入市場，該系統旨在透過將血管分離、電凝和分支結紮整合於單一設備中來簡化血管造影操作。雖然EVH在Zimmer Biomet廣泛的產品系列中佔比相對較小，但Venapax支持微創冠狀動脈旁路移植術（CABG），使該公司成為主要競爭對手之一。

科技和醫療治療的發展趨勢

微創血管採集

微創血管移植術（EVH）仍然是EVH市場的核心趨勢。 EVH裝置減少了大切口的需求，並有助於改善取血管部位的術後效果。

隨著醫生們將康復、患者滿意度和減少傷口併發症放​​在首位，預計這一趨勢還將繼續。

EVH的高滲透率

EVH 的採用率已超過血管採集手術的 90%，預計在預測期內將接近 100%。

儘管冠狀動脈繞道手術 (CABG) 的總數有所下降，但這種高普及率仍然支撐著對該設備持續的需求。

外科功能的整合

一些 EVH 系統將多種功能（如解剖、燒灼和分支結紮）整合到單一設備中。

這簡化了血管採集流程，並提高了冠狀動脈繞道手術的手術效率。

成熟市場的產品創新

EVH市場已趨於成熟，但產品仍在不斷改進。製造商正致力於提升產品的可視性、易用性、設備控制性和手術效率。

隨著平均售價 (ASP) 面臨的壓力增加，這些改進對於保持競爭優勢至關重要。

機器人輔助微創冠狀動脈繞道手術

隨著機器人輔助和微創冠狀動脈繞道手術的增加，對即使在空間有限的環境下也能運作良好的器械的需求也日益成長。

EVH 設備的設計旨在適應有限的手術視野，可能會受益於手術技術的這種轉變。

來自導管替代療法的壓力

由於微創導管介入療法的出現，接受冠狀動脈繞道手術（CABG）的患者數量正在減少。這給包括內視鏡血管成形術（EVH）在內的所有CABG相關器械的市場帶來了壓力。

預計接受冠狀動脈繞道手術的患者群體將包括那些患有複雜病變或多支血管疾病，但仍需要進行外科重組的患者。

地區

本報告涵蓋的全球調查區域包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

這份報告的意義

  • 目前全球內視鏡取血管手術設備市場規模有多大？預計到 2032 年將如何變化？
  • 隨著時間的推移，銷售量、治療量、平均售價（ASP）和市場規模發生了什麼樣的變化？
  • 儘管電動車充電樁市場滲透率很高，但為什麼預期電動車充電樁市場會萎縮？
  • EVH裝置在冠狀動脈繞道手術中扮演什麼角色？
  • EVH 裝置如何減少取皮部位的創傷、疤痕和傷口併發症？
  • CABG手術量的下降對EVH設備的需求有何影響？
  • 競爭對手如何影響平均售價（ASP）和市場價值？
  • 微創和機器人輔助冠狀動脈繞道手術 (CABG) 對 EVH 產品的設計產生了哪些影響？
  • 哪家公司在全球EVH設備市場處於領先地位？
  • Getinge、Terumo 和 Zimmer Biomet 在競爭格局中處於什麼地位？

iData Research 的《全球內內視鏡取血管手術器械市場報告》透過器械層面的分析、手術建模、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。該報告可用於評估需求、與競爭對手進行比較、了解 CABG 相關器材的發展趨勢，並為全球 EVH 器材市場的產業計畫提供支援。

目錄

調查方法

  • 第一步：專案啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟 3：設計和準備訪談和調查問卷。
  • 第四步：進行初步調查
  • 第五步：調查與分析：建立基準估計值
  • 第六步：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟九：客戶回饋與市場監測

全球關稅的影響

內視鏡取血管手術裝置市場

  • 執行摘要
    • 全球內內視鏡取血管手術市場概覽
    • 競爭分析
    • 目標程式
    • 目標區域
  • 介紹
  • 手術次數
    • 使用全內視鏡取血管手術裝置進行手術
    • 完全冠狀動脈旁路移植術
  • 市場分析與預測
  • 促進因素和抑制因素
  • 競爭性市佔率分析

附錄

Product Code: iDATA_GLCS26_EVH_MC

Global Endoscopic Vessel Harvesting Device Market Report to 2032

The global endoscopic vessel harvesting device market was valued at $350.9 million in 2025. It is expected to decrease at a compound annual growth rate (CAGR) of -0.7%, reaching $335 million by 2032.

This report covers the global market for endoscopic vessel harvesting (EVH) devices, including devices used in minimally invasive endoscopy procedures as part of coronary artery bypass grafting.

The analysis includes unit sales, average selling prices (ASPs), procedure numbers, market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market demand is supported by the clinical benefits of EVH and increasing penetration of endoscopic harvesting methods. However, declining CABG procedure volumes and price competition are expected to drive a modest decrease in overall market value.

Market Overview

The global endoscopic vessel harvesting device market includes products used to harvest vessels for coronary artery bypass grafting procedures through a minimally invasive endoscopic approach.

EVH devices allow surgeons to harvest the saphenous vein or other target vessels through smaller incisions compared with open vessel harvesting. This can reduce trauma at the harvest site and support faster patient recovery.

The global volume of coronary artery bypass grafting procedures has declined in recent years as less invasive catheter-based alternatives continue to gain adoption. Transcatheter aortic valve replacement and other catheter-based treatments offer shorter recovery times and reduced surgical trauma, which has shifted treatment patterns away from some open cardiac procedures.

Despite this pressure, CABG remains clinically necessary for complex, multivessel coronary disease. This preserves a stable base of procedures that continue to require vessel harvesting technologies, helping limit the decline of the EVH device market through 2032.

Market Drivers

Clinical Benefits

EVH devices support minimally invasive vessel harvesting by allowing the necessary vessel to be removed through a smaller incision. This reduces trauma at the harvest site compared with open vessel harvesting.

The clinical benefits include reduced scarring, faster recovery, and improved patient satisfaction. These advantages are important because the harvest site can be a major source of discomfort and complications after CABG procedures.

Open vessel harvesting requires a larger incision and is associated with higher risk of wound complications, including dehiscence, hematoma, and infection. By reducing these risks, EVH devices improve patient outcomes and help maintain demand for endoscopic harvesting methods.

Increasing Penetration

EVH penetration is already very high. In 2025, more than 90% of vessel harvesting procedures used the EVH method.

This penetration is expected to continue rising over the forecast period and approach 100%. Physicians continue to prefer EVH because of its short-term and long-term benefits for patients.

Increasing penetration will help support the market even as CABG procedures decline. While total procedural volume may decrease, higher EVH use within the remaining CABG procedure base helps slow the decline of the EVH device market.

Support for Minimally Invasive CABG

The growing adoption of minimally invasive and robotic coronary artery bypass procedures is increasing demand for advanced EVH devices. These procedures place greater emphasis on tools that support limited access and efficient vessel preparation.

Minimally invasive direct CABG and robotic-assisted approaches require precise and reliable device performance. EVH systems that improve visibility, dissection, cautery, and branch ligation can support these more advanced surgical workflows.

Manufacturers are responding by improving device design, ease of use, and procedural efficiency. These product refinements help support continued innovation in the EVH segment, even as broader CABG procedure growth remains limited.

Market Limiters

Declining CABG Procedures

Declining CABG procedure volume is the main limiter for the EVH device market. EVH devices are used only in CABG procedures, which means the market is closely tied to surgical revascularization volumes.

As less invasive catheter-based alternatives continue to gain adoption, the number of CABG procedures performed is expected to decline. This directly limits demand for vessel harvesting devices.

Although EVH devices are expected to decline more slowly than open harvesting methods, the overall market remains constrained by the CABG procedure base. Unless aging population effects are strong enough to reverse current CABG trends, EVH device demand will remain limited.

Competition

Competition is another major limiter in the EVH device market. In developed markets, companies compete heavily on price.

The entry of new players in the United States and Europe, combined with continued competition between established companies, is expected to drive a steady decrease in ASPs.

This ASP pressure will depress market value over the forecast period. Even if EVH penetration increases, lower pricing can offset some of the revenue benefit created by higher usage.

Procedure Mix Pressure

The EVH market is also limited by broader changes in cardiovascular treatment patterns. As catheter-based interventions continue to expand, some patients who might have previously undergone CABG may be treated through less invasive approaches.

This affects EVH because the device is tied to surgical bypass procedures rather than catheter-based treatment. Even strong EVH penetration cannot fully offset a shrinking CABG procedure base.

As treatment pathways continue to shift toward less invasive alternatives where appropriate, EVH suppliers must focus on the remaining surgical patient population, including complex and multivessel disease cases where CABG remains clinically necessary.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.
  • Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
  • Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
  • Market modeling: Revenue is analyzed using unit sales and ASPs, supported by procedure numbers, competitive share analysis, and forecast assumptions.
  • Device scope: The report covers endoscopic vessel harvesting devices used in minimally invasive harvesting procedures performed as part of coronary artery bypass grafting.

Markets Covered and Segmentation

Endoscopic Vessel Harvesting Device Market

The report covers the global endoscopic vessel harvesting device market as a dedicated cardiac surgery device segment.

Endoscopic vessel harvesting devices are used during CABG procedures to harvest vessels through a minimally invasive endoscopic approach. These devices help reduce the incision size required for vessel removal and support improved outcomes at the harvest site.

The market is analyzed by market size, market shares, procedure numbers, market forecasts, market growth rates, units sold, and average selling prices.

The report evaluates EVH demand based on CABG procedure volume, physician adoption, EVH penetration, competitive pricing, product innovation, and the shift toward minimally invasive surgical techniques.

This structure helps manufacturers, investors, and strategy teams understand how CABG trends, vessel harvesting preferences, device pricing, and competitive dynamics are shaping the global EVH market.

Competitive Analysis

Getinge was the leading competitor in the global EVH device market in 2025, dominating the segment with its VASOVIEW(TM) platform.

The company further strengthened its position with the launch of the next-generation VASOVIEW(TM) Hemopro 3 in 2024. This product introduced design and performance enhancements aimed at improving procedural efficiency in minimally invasive CABG procedures.

Supported by its strong installed base and continued product innovation, Getinge is expected to maintain its market share over the coming years.

Terumo was the second-leading competitor in the global EVH device market in 2025. The company offers the VirtuoSaph(TM) and VirtuoSaph(TM) Plus EVH systems.

Terumo is expected to grow its share of the market over the coming years across global regions. Its continued presence in cardiovascular and surgical device markets supports its ability to compete in the EVH segment.

Zimmer Biomet held the third-leading position in the global EVH device market in 2025. The company participates through its Venapax(R) Endoscopic Vessel Harvesting System, which is designed to simplify vessel harvesting by integrating dissection, cautery, and branch ligation into a single device. Although EVH is a relatively small part of Zimmer Biomet's broader portfolio, Venapax supports minimally invasive CABG techniques and positions the company as a key competitor.

Technology and Practice Trends

Minimally Invasive Vessel Harvesting

Minimally invasive vessel harvesting remains the core trend in the EVH market. EVH devices reduce the need for large incisions and support better harvest-site outcomes.

This trend is expected to continue as physicians prioritize recovery, patient satisfaction, and reduced wound complications.

High EVH Penetration

EVH penetration already exceeds 90% of vessel harvesting procedures and is expected to approach 100% over the forecast period.

This high penetration supports continued device demand, even as overall CABG volumes decline.

Integration of Surgical Functions

Some EVH systems integrate multiple functions into a single device, including dissection, cautery, and branch ligation.

This can simplify the vessel harvesting workflow and support procedural efficiency during CABG.

Product Innovation in Mature Markets

EVH is a mature market, but product refinements continue. Manufacturers are improving visibility, ease of use, device control, and procedural efficiency.

These improvements are important for maintaining competitive positioning as ASP pressure continues.

Robotic and Minimally Invasive CABG

Robotic-assisted and minimally invasive CABG procedures are increasing demand for tools that perform well through limited access.

EVH devices that support constrained operative fields may benefit from this procedural shift.

Pressure from Catheter-Based Alternatives

Less invasive catheter-based alternatives are reducing the number of patients undergoing CABG. This creates pressure on all CABG-related device markets, including EVH.

The remaining CABG population is expected to include complex and multivessel disease patients who still require surgical revascularization.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

  • How large is the global endoscopic vessel harvesting device market today, and how is it expected to change through 2032?
  • How are unit sales, procedure numbers, ASPs, and market values changing over time?
  • Why is the EVH market expected to decline despite high penetration?
  • What role do EVH devices play in CABG procedures?
  • How do EVH devices reduce harvest-site trauma, scarring, and wound complications?
  • How is the decline in CABG procedure volume affecting EVH device demand?
  • What impact does competition have on ASPs and market value?
  • How are minimally invasive and robotic CABG procedures influencing EVH product design?
  • Which companies lead the global EVH device market?
  • How are Getinge, Terumo, and Zimmer Biomet positioned in the competitive landscape?

The Global Endoscopic Vessel Harvesting Device Market Report from iData Research answers these questions with device-level analysis, procedure-based modeling, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand CABG-related device trends, and support commercial planning in the global EVH device market.

TABLE OF CONTENT

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Endoscopic Vessel Harvesting Device Market

  • 16.1 Executive Summary
    • 16.1.1 Global Endoscopic Vessel Harvesting Device Market Overview
    • 16.1.2 Competitive Analysis
    • 16.1.3 Procedures Included
    • 16.1.4 Regions Included
  • 16.2 Introduction
  • 16.3 Procedure Numbers
    • 16.3.1 Total Endoscopic Vessel Harvesting Device Procedures
    • 16.3.2 Total CABG Procedures
  • 16.4 Market Analysis And Forecast
  • 16.5 Drivers And Limiters
    • 16.5.1 Market Drivers
    • 16.5.2 Market Limiters
  • 16.6 Competitive Market Share Analysis

Appendix

LIST OF CHARTS

  • Chart 16-1: Endoscopic Vessel Harvesting Device Market, Global, 2025 & 2032
  • Chart 16-2: Endoscopic Vessel Harvesting Device Procedures, Global, 2025
  • Chart 16-3: Endoscopic Vessel Harvesting Procedures by Region, Global, 2022 - 2032
  • Chart 16-4: Endoscopic Vessel Harvesting Device Market, Global, 2022 - 2032
  • Chart 16-5: Leading Competitors, Endoscopic Vessel Harvesting Device Market, Global, 2025

LIST OF FIGURES

  • Figure 16-1: Endoscopic Vessel Harvesting Device Procedures Covered
  • Figure 16-2: Endoscopic Vessel Harvesting Device Regions Covered, Global (1 of 2)
  • Figure 16-3: Endoscopic Vessel Harvesting Device Regions Covered, Global (2 of 2)
  • Figure 16-4: Endoscopic Vessel Harvesting Device Procedures by Region, Global, 2022 - 2032
  • Figure 16-5: CABG Procedures by Region, Global, 2022 - 2032
  • Figure 16-6: Endoscopic Vessel Harvesting Procedures by Country, North America, 2022 - 2032
  • Figure 16-7: Endoscopic Vessel Harvesting Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 16-8: Endoscopic Vessel Harvesting Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 16-9: Endoscopic Vessel Harvesting Procedures by Country, Western Europe, 2022 - 2032
  • Figure 16-10: Endoscopic Vessel Harvesting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 16-11: Endoscopic Vessel Harvesting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 16-12: Endoscopic Vessel Harvesting Procedures by Country, Middle East, 2022 - 2032
  • Figure 16-13: Endoscopic Vessel Harvesting Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 16-14: Endoscopic Vessel Harvesting Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 16-15: Endoscopic Vessel Harvesting Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 16-16: Endoscopic Vessel Harvesting Procedures by Country, Africa, 2022 - 2032
  • Figure 16-17: Endoscopic Vessel Harvesting Device Market, Global, 2022 - 2032
  • Figure 16-18: Units Sold by Region, Endoscopic Vessel Harvesting Device Market, Global, 2022 - 2032
  • Figure 16-19: Average Selling Price by Region, Endoscopic Vessel Harvesting Device Market, Global, 2022 - 2032 (US$)
  • Figure 16-20: Market Value by Region, Endoscopic Vessel Harvesting Device Market, Global, 2022 - 2032 (US$M)
  • Figure 16-21: Leading Competitors, Endoscopic Vessel Harvesting Device Market, Global, 2025